COMPLETED

taVNS on Pupillary Response and Perceptual Learning

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study has two parts. The study team will evaluate transcutaneous auricular vagal nerve stimulation (taVNS) and two sham settings during a passive task while measuring pupillary response. Second, the study team will assign either taVNS, sham, or no intervention during a go/no-go task and evaluate perceptual learning over three sessions which will also include measuring the pupillary response and electroencephalogram (EEG).

Official Title

The Effect of Transcutaneous Auricular Vagal Nerve Stimulation (taVNS) on Pupillary Response and Perceptual Learning

Quick Facts

Study Start:2022-05-18
Study Completion:2025-07-09
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:COMPLETED

Study ID

NCT05386563

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 65 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Healthy individuals 18 to 65
  2. * Normal audiometric testing
  1. * Co-morbidities including cardiomyopathies, arrhythmias
  2. * Implantable devices including vagal stimulators, pacemakers
  3. * Presence of metallic implants
  4. * Pregnancy

Contacts and Locations

Principal Investigator

Mario Svirsky, PhD
PRINCIPAL_INVESTIGATOR
NYU Langone Health

Study Locations (Sites)

NYU Langone Health - Bellevue Hospital
New York, New York, 10016
United States

Collaborators and Investigators

Sponsor: NYU Langone Health

  • Mario Svirsky, PhD, PRINCIPAL_INVESTIGATOR, NYU Langone Health

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-05-18
Study Completion Date2025-07-09

Study Record Updates

Study Start Date2022-05-18
Study Completion Date2025-07-09

Terms related to this study

Additional Relevant MeSH Terms

  • Pupillary Response